PL373425A1 - Podstawione benzoizoksazolosulfonoamidy jako inhibitory proteaz HIV o szerokim spektrum działania - Google Patents
Podstawione benzoizoksazolosulfonoamidy jako inhibitory proteaz HIV o szerokim spektrum działaniaInfo
- Publication number
- PL373425A1 PL373425A1 PL03373425A PL37342503A PL373425A1 PL 373425 A1 PL373425 A1 PL 373425A1 PL 03373425 A PL03373425 A PL 03373425A PL 37342503 A PL37342503 A PL 37342503A PL 373425 A1 PL373425 A1 PL 373425A1
- Authority
- PL
- Poland
- Prior art keywords
- protease inhibitors
- hiv protease
- substituted benzisoxazole
- sulfonamide hiv
- broadspectrum
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02076957 | 2002-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL373425A1 true PL373425A1 (pl) | 2005-08-22 |
Family
ID=29433159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03373425A PL373425A1 (pl) | 2002-05-17 | 2003-05-16 | Podstawione benzoizoksazolosulfonoamidy jako inhibitory proteaz HIV o szerokim spektrum działania |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US7462636B2 (pl) |
| EP (1) | EP1517899B1 (pl) |
| JP (2) | JP4674084B2 (pl) |
| KR (2) | KR20100130234A (pl) |
| CN (1) | CN100582097C (pl) |
| AP (1) | AP2004003190A0 (pl) |
| AR (1) | AR039887A1 (pl) |
| AT (1) | ATE371652T1 (pl) |
| AU (1) | AU2003238074B2 (pl) |
| BR (1) | BR0310089A (pl) |
| CA (1) | CA2485903C (pl) |
| CY (1) | CY1107040T1 (pl) |
| DE (1) | DE60315984T2 (pl) |
| DK (1) | DK1517899T3 (pl) |
| EA (1) | EA010908B1 (pl) |
| ES (1) | ES2292976T3 (pl) |
| HK (1) | HK1076099A1 (pl) |
| HR (1) | HRP20050607B1 (pl) |
| IL (1) | IL165043A0 (pl) |
| MX (1) | MXPA04011466A (pl) |
| MY (1) | MY135226A (pl) |
| NO (1) | NO330184B1 (pl) |
| NZ (1) | NZ536496A (pl) |
| PL (1) | PL373425A1 (pl) |
| PT (1) | PT1517899E (pl) |
| SI (1) | SI1517899T1 (pl) |
| TW (1) | TWI356700B (pl) |
| WO (1) | WO2003097616A1 (pl) |
| ZA (1) | ZA200410156B (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL373425A1 (pl) * | 2002-05-17 | 2005-08-22 | Tibotec Pharmaceuticals Ltd. | Podstawione benzoizoksazolosulfonoamidy jako inhibitory proteaz HIV o szerokim spektrum działania |
| CN1953964A (zh) * | 2004-03-11 | 2007-04-25 | 塞阔伊亚药品公司 | 抗耐药性反转录病毒蛋白酶抑制剂 |
| CA2566340C (en) * | 2004-05-07 | 2014-05-06 | Sequoia Pharmaceuticals, Inc. | Resistance-repellent retroviral protease inhibitors |
| BRPI0607827B8 (pt) | 2005-02-25 | 2021-05-25 | Janssen R & D Ireland | composto precursor de inibidor de protease, processo para a produção do referido composto e seu uso |
| CN101702908A (zh) * | 2007-03-23 | 2010-05-05 | 麻萨诸塞州大学 | Hiv-1蛋白酶抑制剂 |
| US8216495B2 (en) * | 2008-03-25 | 2012-07-10 | Formac Pharmaceuticals N.V. | Preparation method for solid dispersions |
| WO2011061590A1 (en) | 2009-11-17 | 2011-05-26 | Hetero Research Foundation | Novel carboxamide derivatives as hiv inhibitors |
| DE102010004957A1 (de) | 2010-01-14 | 2011-07-21 | Universitätsklinikum Jena, 07743 | Biologisch wirksame Moleküle zur Beeinflussung von Virus-, Bakterien-, Parasiten-infizierten Zellen und/oder Tumorzellen und Verfahren zu deren Anwendung |
| EP2914587A1 (de) | 2012-10-31 | 2015-09-09 | Bayer CropScience AG | Neue heterocylische verbindungen als schädlingsbekämpfungsmittel |
| BR112015015846A2 (pt) | 2013-03-07 | 2017-07-11 | Dow Global Technologies Llc | éter de celulose esterificado, composição, dispersão sólida, forma de dosagem, invólucro de cápsula e processo para produzir um éter de celulose esterificado |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5004751A (en) * | 1987-08-28 | 1991-04-02 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| KR100336699B1 (ko) * | 1992-08-25 | 2002-05-13 | 윌리암스 로저 에이 | 레트로바이러스 프로테아제 저해제로서 유용한히드록시에틸아미노 술폰아미드 |
| PH30929A (en) | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
| IS2334B (is) | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
| ES2127938T3 (es) | 1993-08-24 | 1999-05-01 | Searle & Co | Hidroxietilamino sulfonamidas utiles como inhibidores de proteasas retroviricas. |
| DK0721331T3 (da) | 1993-10-01 | 2002-02-11 | Astrazeneca Ab | Fremgangsmåde |
| CA2210889C (en) * | 1995-01-20 | 2007-08-28 | G.D. Searle & Co. | Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| US5756533A (en) * | 1995-03-10 | 1998-05-26 | G.D. Searle & Co. | Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| US5705500A (en) | 1995-03-10 | 1998-01-06 | G.D. Searle & Co. | Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| US6150556A (en) * | 1995-03-10 | 2000-11-21 | G. D. Dearle & Co. | Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| PL184771B1 (pl) | 1995-03-10 | 2002-12-31 | Searle & Co | Związek stanowiący hydroksyetyloaminosulfonamid pirolidynokarbonyloaminokwasu, kompozycja zawierająca ten związek, jego zastosowanie do wytwarzania kompozycji do leczenia infekcji retrowirusowej i sposób zapobiegania replikacji retrowirusa in vitro |
| AU7722296A (en) | 1995-11-15 | 1997-06-05 | G.D. Searle & Co. | Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| EE03902B1 (et) | 1996-05-20 | 2002-12-16 | Janssen Pharmaceutica N.V. | Osakesed, nende valmistamismeetod ja kasutamine, farmatseutiline doseerimisvorm ja selle valmistamismeetod, tahke dispersioon ning farmatseutiline pakend |
| ATE241969T1 (de) | 1997-03-26 | 2003-06-15 | Janssen Pharmaceutica Nv | Tabletten mit einem kern, der mit einem pilzbekämpfungsmittel und einem polymeren beschichtet ist |
| AU2012199A (en) | 1997-12-24 | 1999-07-19 | Vertex Pharmaceuticals Incorporated | Prodrugs of aspartyl protease inhibitors |
| ID25551A (id) | 1997-12-24 | 2000-10-12 | Vertex Pharma | Bahan baku obat penghambat protease aspartil |
| AU2010299A (en) | 1997-12-24 | 1999-07-19 | Vertex Pharmaceuticals Incorporated | Prodrugs os aspartyl protease inhibitors |
| US6436989B1 (en) | 1997-12-24 | 2002-08-20 | Vertex Pharmaceuticals, Incorporated | Prodrugs of aspartyl protease inhibitors |
| DK1088098T4 (en) * | 1998-06-23 | 2015-09-14 | Us Of America Represented By The Secretary Dept Of Health And Human Services | Fitnessassay and methods for reducing HIV resistance to therapy |
| AU4828199A (en) | 1998-06-23 | 2000-01-10 | Board Of Trustees Of The University Of Illinois, The | Multi-drug resistant retroviral protease inhibitors and associated methods |
| CN1191256C (zh) | 1999-10-06 | 2005-03-02 | 泰博特克药品有限公司 | 作为逆转录病毒蛋白酶抑制剂的六氢呋喃并[2,3－b]呋喃－3－基－N－{3－[(1,3－苯并二氧杂环戊－5－基磺酰基)(异丁基)氨基)－1苄基－2－羟丙基}氨基甲酸酯 |
| PL367084A1 (pl) * | 2001-04-09 | 2005-02-21 | Tibotec Pharmaceuticals Ltd. | Sulfonoamidy 2-(podstawionego-amino) benzoksazolujako inhibitory proteazy HIV o szerokim zakresie działania |
| PL373425A1 (pl) * | 2002-05-17 | 2005-08-22 | Tibotec Pharmaceuticals Ltd. | Podstawione benzoizoksazolosulfonoamidy jako inhibitory proteaz HIV o szerokim spektrum działania |
-
2003
- 2003-05-16 PL PL03373425A patent/PL373425A1/pl unknown
- 2003-05-16 AP AP2004003190A patent/AP2004003190A0/xx unknown
- 2003-05-16 WO PCT/EP2003/050173 patent/WO2003097616A1/en active IP Right Grant
- 2003-05-16 CA CA2485903A patent/CA2485903C/en not_active Expired - Fee Related
- 2003-05-16 IL IL16504303A patent/IL165043A0/xx not_active IP Right Cessation
- 2003-05-16 EP EP03735707A patent/EP1517899B1/en not_active Expired - Lifetime
- 2003-05-16 BR BR0310089-8A patent/BR0310089A/pt not_active IP Right Cessation
- 2003-05-16 EA EA200401524A patent/EA010908B1/ru not_active IP Right Cessation
- 2003-05-16 DK DK03735707T patent/DK1517899T3/da active
- 2003-05-16 NZ NZ536496A patent/NZ536496A/en not_active IP Right Cessation
- 2003-05-16 MX MXPA04011466A patent/MXPA04011466A/es active IP Right Grant
- 2003-05-16 JP JP2004505349A patent/JP4674084B2/ja not_active Expired - Fee Related
- 2003-05-16 AU AU2003238074A patent/AU2003238074B2/en not_active Ceased
- 2003-05-16 KR KR1020107025714A patent/KR20100130234A/ko not_active Application Discontinuation
- 2003-05-16 TW TW092113367A patent/TWI356700B/zh not_active IP Right Cessation
- 2003-05-16 AT AT03735707T patent/ATE371652T1/de active
- 2003-05-16 PT PT03735707T patent/PT1517899E/pt unknown
- 2003-05-16 SI SI200331012T patent/SI1517899T1/sl unknown
- 2003-05-16 AR ARP030101725A patent/AR039887A1/es active IP Right Grant
- 2003-05-16 KR KR1020047018261A patent/KR101019648B1/ko not_active IP Right Cessation
- 2003-05-16 DE DE60315984T patent/DE60315984T2/de not_active Expired - Lifetime
- 2003-05-16 CN CN03816458A patent/CN100582097C/zh not_active Expired - Fee Related
- 2003-05-16 ES ES03735707T patent/ES2292976T3/es not_active Expired - Lifetime
- 2003-05-16 MY MYPI20031819A patent/MY135226A/en unknown
- 2003-05-16 US US10/514,539 patent/US7462636B2/en not_active Expired - Fee Related
-
2004
- 2004-12-14 NO NO20045444A patent/NO330184B1/no not_active IP Right Cessation
- 2004-12-15 ZA ZA2004/10156A patent/ZA200410156B/en unknown
-
2005
- 2005-06-29 HR HRP20050607AA patent/HRP20050607B1/hr not_active IP Right Cessation
- 2005-09-14 HK HK05108052A patent/HK1076099A1/xx not_active IP Right Cessation
-
2007
- 2007-11-29 CY CY20071101524T patent/CY1107040T1/el unknown
-
2010
- 2010-10-25 JP JP2010238833A patent/JP2011051999A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1076099A1 (en) | Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors | |
| IL179056A0 (en) | An hiv protease inhibitor | |
| EP1483254A4 (en) | INHIBITORS OF ANTI-RESISTANCE RETROVIRAL PROTEASE | |
| EP1499336A4 (en) | PROTEASE INHIBITORS | |
| IL166257A0 (en) | Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors | |
| AP2003002856A0 (en) | Broadspectrum 2-(substitutted-amino)-benzothiazolesulphonamide HIV protease inhibitors. | |
| HK1070001A1 (en) | Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors | |
| IL158093A0 (en) | Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors | |
| EP1704142A4 (en) | PROTEASE INHIBITORS | |
| HK1072053A1 (en) | Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors | |
| PL375307A1 (pl) | Podstawione oksoindolo sulfonamidy jako inhibitory proteazy HIV o szerokim zakresie działania | |
| AU2003269984A8 (en) | Protease inhibitors | |
| ZA200500926B (en) | Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors | |
| AU2003263738A8 (en) | Protease inhibitors | |
| AU2003287325A8 (en) | N-cycloalkylglycines as hiv protease inhibitors | |
| AU2003233642A8 (en) | Protease inhibitors | |
| AU2003304496A8 (en) | Protease inhibitors | |
| AU2003265240A8 (en) | Protease inhibitors | |
| AU2003269878A8 (en) | Protease inhibitors | |
| AU2002255485A8 (en) | Hiv/fiv protease inhibitors | |
| TWI340135B (en) | Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors | |
| AU2003230545A1 (en) | Resistance-repellent retroviral protease inhibitors |